970 related articles for article (PubMed ID: 15189148)
1. The Sir2 family of protein deacetylases.
Blander G; Guarente L
Annu Rev Biochem; 2004; 73():417-35. PubMed ID: 15189148
[TBL] [Abstract][Full Text] [Related]
2. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
Sauve AA; Schramm VL
Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
[TBL] [Abstract][Full Text] [Related]
3. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
Khan AN; Lewis PN
J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
[TBL] [Abstract][Full Text] [Related]
4. Sir Antagonist 1 (San1) is a ubiquitin ligase.
Dasgupta A; Ramsey KL; Smith JS; Auble DT
J Biol Chem; 2004 Jun; 279(26):26830-8. PubMed ID: 15078868
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
Zhao K; Harshaw R; Chai X; Marmorstein R
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
[TBL] [Abstract][Full Text] [Related]
7. Budding yeast silencing complexes and regulation of Sir2 activity by protein-protein interactions.
Tanny JC; Kirkpatrick DS; Gerber SA; Gygi SP; Moazed D
Mol Cell Biol; 2004 Aug; 24(16):6931-46. PubMed ID: 15282295
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
Avalos JL; Bever KM; Wolberger C
Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
[TBL] [Abstract][Full Text] [Related]
9. Structure of the coiled-coil dimerization motif of Sir4 and its interaction with Sir3.
Chang JF; Hall BE; Tanny JC; Moazed D; Filman D; Ellenberger T
Structure; 2003 Jun; 11(6):637-49. PubMed ID: 12791253
[TBL] [Abstract][Full Text] [Related]
10. Bypassing Sir2 and O-acetyl-ADP-ribose in transcriptional silencing.
Chou CC; Li YC; Gartenberg MR
Mol Cell; 2008 Sep; 31(5):650-9. PubMed ID: 18775325
[TBL] [Abstract][Full Text] [Related]
11. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation.
Liou GG; Tanny JC; Kruger RG; Walz T; Moazed D
Cell; 2005 May; 121(4):515-527. PubMed ID: 15907466
[TBL] [Abstract][Full Text] [Related]
12. A nonhistone protein-protein interaction required for assembly of the SIR complex and silent chromatin.
Rudner AD; Hall BE; Ellenberger T; Moazed D
Mol Cell Biol; 2005 Jun; 25(11):4514-28. PubMed ID: 15899856
[TBL] [Abstract][Full Text] [Related]
13. Steps in assembly of silent chromatin in yeast: Sir3-independent binding of a Sir2/Sir4 complex to silencers and role for Sir2-dependent deacetylation.
Hoppe GJ; Tanny JC; Rudner AD; Gerber SA; Danaie S; Gygi SP; Moazed D
Mol Cell Biol; 2002 Jun; 22(12):4167-80. PubMed ID: 12024030
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
Bitterman KJ; Anderson RM; Cohen HY; Latorre-Esteves M; Sinclair DA
J Biol Chem; 2002 Nov; 277(47):45099-107. PubMed ID: 12297502
[TBL] [Abstract][Full Text] [Related]
15. SIR2 is required for polycomb silencing and is associated with an E(Z) histone methyltransferase complex.
Furuyama T; Banerjee R; Breen TR; Harte PJ
Curr Biol; 2004 Oct; 14(20):1812-21. PubMed ID: 15498488
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
Imai S; Armstrong CM; Kaeberlein M; Guarente L
Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
[TBL] [Abstract][Full Text] [Related]
17. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
Howitz KT; Bitterman KJ; Cohen HY; Lamming DW; Lavu S; Wood JG; Zipkin RE; Chung P; Kisielewski A; Zhang LL; Scherer B; Sinclair DA
Nature; 2003 Sep; 425(6954):191-6. PubMed ID: 12939617
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the NAD-dependent deacetylase mechanism of Sir2.
Chang JH; Kim HC; Hwang KY; Lee JW; Jackson SP; Bell SD; Cho Y
J Biol Chem; 2002 Sep; 277(37):34489-98. PubMed ID: 12091395
[TBL] [Abstract][Full Text] [Related]
19. Swapping the gene-specific and regional silencing specificities of the Hst1 and Sir2 histone deacetylases.
Mead J; McCord R; Youngster L; Sharma M; Gartenberg MR; Vershon AK
Mol Cell Biol; 2007 Apr; 27(7):2466-75. PubMed ID: 17242192
[TBL] [Abstract][Full Text] [Related]
20. Human Sir2 and the 'silencing' of p53 activity.
Smith J
Trends Cell Biol; 2002 Sep; 12(9):404-6. PubMed ID: 12220851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
